List View

By /

Clear

Displaying 2,876 - 2,900 of 2,995

Marijuana in Cancer Patients?

Marijuana in Cancer Patients?

Management of Oligometastatic Disease in the Liver By Interventional Radiology: Novel Advances

Management of Oligometastatic Disease in the Liver By Interventional Radiology: Novel Advances

2024-2025 Updates in Radiation Oncology

2024-2025 Updates in Radiation Oncology

Survivorship in the Modern Era of Cancer Care

Survivorship in the Modern Era of Cancer Care

Artificial Intelligence in Cancer 2025

Artificial Intelligence in Cancer 2025

Novel Advances in Ovarian and Uterine Cancers

Novel Advances in Ovarian and Uterine Cancers

Squamous Cell Carcinoma of Head and Neck

Squamous Cell Carcinoma of Head and Neck

Sarcoma: Applying Molecular Medicine to Improve Outcomes

Sarcoma: Applying Molecular Medicine to Improve Outcomes

Novel Advances in Prostate Cancer

Novel Advances in Prostate Cancer

Kidney Cancer: Targeted and Immunotherapy Approaches

Kidney Cancer: Targeted and Immunotherapy Approaches

Are We Moving Away from Cystectomy for Bladder Cancer? The Art and Science of Selection

Are We Moving Away from Cystectomy for Bladder Cancer? The Art and Science of Selection

Neuro Oncology: Novel Advances in Glioma Therapy

Neuro Oncology: Novel Advances in Glioma Therapy

New Therapeutic Approaches for Esophageal and Gastric Cancer

New Therapeutic Approaches for Esophageal and Gastric Cancer

Beyond Just Chemotherapy in Colorectal Cancer

Beyond Just Chemotherapy in Colorectal Cancer

Pancreas, Liver and Biliary Tract Malignancies: Updates

Pancreas, Liver and Biliary Tract Malignancies: Updates

Limited- and Extensive-Disease Small Cell Lung Cancer (SCLC): New Standard of Care and Novel Advances

Limited- and Extensive-Disease Small Cell Lung Cancer (SCLC): New Standard of Care and Novel Advances

Neoadjuvant-Adjuvant-Perioperative Immunotherapy in NSCLC

Neoadjuvant-Adjuvant-Perioperative Immunotherapy in NSCLC

Immunotherapy for NSCLC: First Line and What Is After Progression?

Immunotherapy for NSCLC: First Line and What Is After Progression?

First-Line Targeted Therapies in NSCLC: What’s New?

First-Line Targeted Therapies in NSCLC: What’s New?

Novel Treatments in NSCLC: Antibody Drug Conjugates (ADC), Bi-Specifics and Vaccines

Novel Treatments in NSCLC: Antibody Drug Conjugates (ADC), Bi-Specifics and Vaccines

Integrative Approaches to Improve Sleep During Cancer Treatment and Survivorship

Integrative Approaches to Improve Sleep During Cancer Treatment and Survivorship

End-of-Life Management: Oncologists’ Perspectives

End-of-Life Management: Oncologists’ Perspectives

Antibody Drug Conjugates for HER2 Negative Breast Cancer: A Revolution in Chemotherapy for Breast Cancer

Antibody Drug Conjugates for HER2 Negative Breast Cancer: A Revolution in Chemotherapy for Breast Cancer

HER-2 Disease: From NeoAdjuvant to Metastatic Setting

HER-2 Disease: From NeoAdjuvant to Metastatic Setting